Illumina (XTER:ILU) Current Accrued Expense : €616 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Illumina Current Accrued Expense?

Illumina's Current Accrued Expense for the quarter that ended in Mar. 2024 was €616 Mil.

Illumina's quarterly Current Accrued Expense increased from Sep. 2023 (€614 Mil) to Dec. 2023 (€628 Mil) but then declined from Dec. 2023 (€628 Mil) to Mar. 2024 (€616 Mil).

Illumina's annual Current Accrued Expense increased from Dec. 2021 (€104 Mil) to Dec. 2022 (€591 Mil) and increased from Dec. 2022 (€591 Mil) to Dec. 2023 (€628 Mil).

Illumina Current Accrued Expense Historical Data

The historical data trend for Illumina's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Current Accrued Expense Chart

Illumina Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

57.60

68.23

103.55

590.94

628.15

Illumina Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															598.69	592.57	613.74	628.15	616.40

Illumina Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Illumina Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Illumina's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Illumina (XTER:ILU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (XTER:ILU) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

ILMN:USA ILMN:Mexico 1ILMN:Italy ILMN:Austria

Address

5200 Illumina Way, San Diego, CA, USA, 92122

Website

https://www.illumina.com

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina (XTER:ILU) Headlines

No Headlines